+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Upstream Bioprocessing Market by Product, Technology, Application, End User, Scale, Cell Type - Global Forecast to 2030- Product Image
Upstream Bioprocessing Market by Product, Technology, Application, End User, Scale, Cell Type - Global Forecast to 2030- Product Image
Sale

Upstream Bioprocessing Market by Product, Technology, Application, End User, Scale, Cell Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5612832
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Upstream Bioprocessing Market grew from USD 12.09 billion in 2024 to USD 13.81 billion in 2025. It is expected to continue growing at a CAGR of 13.65%, reaching USD 26.07 billion by 2030.

Pioneering the Next Wave of Bioprocessing Innovation

The upstream bioprocessing sector stands at the forefront of biopharmaceutical innovation, driven by advances in cell culture technologies and a growing demand for biologics. As the industry seeks to deliver safer, more effective therapies to patients worldwide, the processes that support cell growth and protein expression have become critically important. In recent years, manufacturers have faced mounting pressure to accelerate development timelines, enhance operational flexibility, and reduce overall production costs without compromising quality.

This executive summary offers a concise yet comprehensive overview of the transformative shifts, regulatory challenges, and market dynamics shaping the upstream landscape. By examining tariff impacts, deep-dive segmentation, regional nuances, and the strategic positioning of leading suppliers, stakeholders will gain a clear understanding of the forces sculpting the next generation of biologic manufacturing. As you navigate these insights, you will be equipped with the knowledge needed to make informed decisions, capitalize on emerging opportunities, and mitigate key risks in one of the most dynamic sectors of modern life sciences.

Shifting Paradigms Reshaping the Upstream Bioprocessing Arena

The upstream bioprocessing landscape is undergoing a profound metamorphosis as technological breakthroughs and strategic imperatives converge. Single-use systems have moved from niche applications to widespread adoption, streamlining changeovers and reducing cross-contamination risks. At the same time, the integration of digital tools-ranging from real-time sensor analytics to machine learning-driven process optimization-has ushered in an era of predictive control, enabling manufacturers to respond swiftly to perturbations and maintain consistent product quality.

Regulatory bodies across key markets are also evolving their frameworks to accommodate novel modalities and continuous processing approaches. This shift-from traditional batch paradigms toward modular, closed-system operations-reflects a broader industry commitment to sustainability, as companies seek to minimize water and energy consumption while maximizing yield. As environmental footprint considerations become increasingly pivotal, these transformative trends are setting new benchmarks for efficiency and resilience across the bioprocessing value chain.

Evaluating the Ripple Effects of United States Tariffs in 2025

The introduction of new tariff measures by the United States in 2025 has reverberated throughout the global bioprocessing ecosystem, introducing both challenges and strategic recalibrations. Equipment imports-spanning single-use bioreactors to specialized sensors-have experienced cost escalations, prompting many end users to rethink their sourcing strategies. Meanwhile, the supply chain for critical media components and reagents has felt heightened volatility as distributors adjust pricing to account for increased duties and shipping complexities.

In response, manufacturers and suppliers are exploring alternative trade corridors and relocating certain production stages closer to key end-market clusters. This realignment aims to buffer against future tariff adjustments and mitigate lead-time uncertainties. While short-term price fluctuations have put pressure on operating margins, these strategic maneuvers are poised to engender greater long-run stability and supply security, thereby helping organizations navigate an increasingly protectionist global trade environment.

Unveiling Deep-Dive Segmentation Insights Across Multiple Dimensions

A detailed examination of the market through the prism of product categories reveals a broad spectrum of offerings that cater to diverse upstream needs. From accessories and consumables to elaborate single-use equipment configurations, each segment presents unique performance attributes and cost considerations. Notably, media and reagents-divided into basal media, chemically defined media, and serum-free formulations alongside buffers, cell culture supplements, and growth factors-continue to drive innovation as end users seek to maximize cell densities and product titers under reproducible conditions.

Technology segmentation further underscores the heterogeneity within upstream workflows. Airlift, fixed-bed, stirred-tank, wave, and single-use bioreactors each deliver distinct mixing dynamics, oxygen transfer rates, and scalability profiles, enabling developers to tailor processes for applications ranging from early-stage discovery to commercial-scale production. Application-based insights highlight prioritized growth areas, including cell and gene therapy vector manufacturing alongside monoclonal antibody, recombinant protein, and vaccine production, all of which demand rigorous process control to ensure safety and efficacy.

End users span academic and research institutes, biopharmaceutical innovators, contract research organizations, and government laboratories, each leveraging upstream platforms to address specific scientific objectives. Within these domains, scale considerations-encompassing lab, pilot, and large-scale operations-determine the choice of instrumentation and facility investments. Finally, the underlying biology, whether insect, mammalian, microbial, or plant cell culture, dictates media requirements, bioreactor designs, and downstream integration strategies, illustrating how cell type drives the foundational architecture of bioprocessing campaigns.

Regional Dynamics Driving Global Bioprocessing Growth

Regional landscapes for upstream bioprocessing are shaped by a confluence of market maturity, regulatory frameworks, and investment climates. In the Americas, a robust network of contract service providers and a deep pool of biotech innovation have created a dynamic environment where large-scale deployments and cutting-edge research coexist. The United States remains a hotbed for continuous processing pilots and advanced single-use installations, supported by incentives that accelerate biologics development.

Across Europe, the Middle East & Africa, cost containment initiatives and harmonization of regulatory standards have fostered gradual adoption of modular, flexible systems. Public-private partnerships in key countries are channeling resources into sustainable biomanufacturing hubs, with an emphasis on reducing carbon footprints and promoting circular economy practices. Meanwhile, Asia-Pacific has emerged as a high-velocity growth arena, where rapidly expanding domestic biopharma sectors in China and India are driving demand for high-throughput cell culture platforms and localized reagent supply chains. Japan, South Korea, and Australia continue to push the envelope in digital bioprocessing, integrating automation and remote monitoring to optimize resource utilization.

Strategic Positioning of Leading Bioprocessing Players

Leading suppliers have established their market foothold by offering end-to-end solutions that encompass equipment, consumables, and digital services. Global conglomerates leverage extensive service networks and deep R&D investment to maintain broad portfolios that address every stage of upstream operations. In parallel, specialized biotech firms are carving out niches with advanced single-use sensor technologies and bespoke media formulations designed for emerging cell and gene therapies.

Strategic partnerships between instrumentation providers and software developers are accelerating the deployment of integrated bioprocess control platforms, enabling seamless data flow from bioreactor to analytics dashboard. Some innovators are venturing into predictive modeling and artificial intelligence to offer real-time insights into cell metabolism and process deviations. As competition intensifies, alliances and acquisitions remain key tactics for companies seeking to bolster their technological capabilities and expand their geographic reach.

Actionable Recommendations to Navigate a Complex Bioprocessing Landscape

To thrive amid evolving market dynamics, industry leaders must fortify supply chain resilience by diversifying their network of raw-material sources and forging stronger collaborations with logistics partners. Embracing flexible manufacturing paradigms-such as modular cleanrooms and portable single-use systems-will empower organizations to pivot rapidly in response to demand fluctuations and regulatory shifts.

Investments in digital infrastructure are no longer optional; by integrating advanced process analytics and control software, companies can achieve unprecedented levels of process consistency and accelerate technology transfer across sites. Moreover, pursuing sustainability goals through water and energy-saving initiatives will enhance corporate reputation and align with tightening environmental regulations. Engagement with regulatory agencies to co-develop guidelines for novel modalities will smooth approval pathways and usher innovative therapies to market more efficiently.

Robust Methodology Underpinning the Analysis

This analysis draws upon a rigorous multi-step methodology designed to ensure accuracy and depth. Primary research involved in-depth interviews with senior bioprocessing executives, R&D heads, and regulatory advisors across major markets. Secondary research encompassed peer-reviewed journals, industry whitepapers, and official government publications to capture the latest regulatory updates and technological breakthroughs.

Quantitative data were collated and triangulated from proprietary databases, financial reports, and market intelligence platforms to validate emerging trends and competitive positioning. The insights were continuously reviewed by subject-matter experts to refine interpretations and identify potential blind spots. Together, these methodological pillars support a robust perspective on the upstream bioprocessing sector without relying on speculative market forecasts.

Concluding Perspectives on Upstream Bioprocessing Evolution

As the upstream bioprocessing landscape evolves, stakeholders will need to balance speed, cost, and quality to remain competitive. The convergence of single-use innovation, digital transformation, and sustainability imperatives is setting a new blueprint for biologic manufacturing. By understanding tariff impacts, segmentation nuances, regional variances, and the strategic moves of key players, organizations can craft resilient strategies that anticipate disruptions and harness opportunities.

Looking ahead, the integration of continuous processing and real-time monitoring will become increasingly mainstream, driving higher efficiency and lower risk. Companies that cultivate agile cultures, invest in advanced analytics, and maintain proactive regulatory engagement will be best positioned to lead the next chapter of bioprocessing excellence.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product
    • Accessories And Consumables
    • Bioreactors
    • Media And Reagents
      • Media
        • Basal Media
        • Chemically Defined Media
        • Serum-Free Media
      • Reagents
        • Buffers And Salts
        • Cell Culture Supplements
        • Growth Factors
    • Sensors And Probes
    • Single-Use Equipment
  • Technology
    • Airlift Bioreactors
    • Fixed-Bed Bioreactors
    • Single-Use Bioreactors
    • Stirred-Tank Bioreactors
    • Wave Bioreactors
  • Application
    • Cell Therapy Production
    • Gene Therapy Vector Production
    • Monoclonal Antibody Production
    • Recombinant Protein Production
    • Vaccine Production
  • End User
    • Academic And Research Institutes
    • Biopharmaceutical Companies
    • Contract Research Organizations
    • Government Laboratories
  • Scale
    • Lab Scale
    • Large Scale
    • Pilot Scale
  • Cell Type
    • Insect Cell Culture
    • Mammalian Cell Culture
    • Microbial Fermentation
    • Plant Cell Culture
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Sartorius AG
  • Merck KGaA
  • Lonza Group AG
  • Corning Incorporated
  • Eppendorf AG
  • Bio-Rad Laboratories, Inc.
  • Repligen Corporation
  • Takara Bio Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Upstream Bioprocessing Market, by Product
8.1. Introduction
8.2. Accessories And Consumables
8.3. Bioreactors
8.4. Media And Reagents
8.4.1. Media
8.4.1.1. Basal Media
8.4.1.2. Chemically Defined Media
8.4.1.3. Serum-Free Media
8.4.2. Reagents
8.4.2.1. Buffers And Salts
8.4.2.2. Cell Culture Supplements
8.4.2.3. Growth Factors
8.5. Sensors And Probes
8.6. Single-Use Equipment
9. Upstream Bioprocessing Market, by Technology
9.1. Introduction
9.2. Airlift Bioreactors
9.3. Fixed-Bed Bioreactors
9.4. Single-Use Bioreactors
9.5. Stirred-Tank Bioreactors
9.6. Wave Bioreactors
10. Upstream Bioprocessing Market, by Application
10.1. Introduction
10.2. Cell Therapy Production
10.3. Gene Therapy Vector Production
10.4. Monoclonal Antibody Production
10.5. Recombinant Protein Production
10.6. Vaccine Production
11. Upstream Bioprocessing Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Biopharmaceutical Companies
11.4. Contract Research Organizations
11.5. Government Laboratories
12. Upstream Bioprocessing Market, by Scale
12.1. Introduction
12.2. Lab Scale
12.3. Large Scale
12.4. Pilot Scale
13. Upstream Bioprocessing Market, by Cell Type
13.1. Introduction
13.2. Insect Cell Culture
13.3. Mammalian Cell Culture
13.4. Microbial Fermentation
13.5. Plant Cell Culture
14. Americas Upstream Bioprocessing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Upstream Bioprocessing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Upstream Bioprocessing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Danaher Corporation
17.3.3. Sartorius AG
17.3.4. Merck KGaA
17.3.5. Lonza Group AG
17.3.6. Corning Incorporated
17.3.7. Eppendorf AG
17.3.8. Bio-Rad Laboratories, Inc.
17.3.9. Repligen Corporation
17.3.10. Takara Bio Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. UPSTREAM BIOPROCESSING MARKET MULTI-CURRENCY
FIGURE 2. UPSTREAM BIOPROCESSING MARKET MULTI-LANGUAGE
FIGURE 3. UPSTREAM BIOPROCESSING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. UPSTREAM BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. UPSTREAM BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. UPSTREAM BIOPROCESSING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BASAL MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CHEMICALLY DEFINED MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BUFFERS AND SALTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL CULTURE SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SENSORS AND PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SINGLE-USE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY AIRLIFT BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY FIXED-BED BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY STIRRED-TANK BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY WAVE BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL THERAPY PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY GENE THERAPY VECTOR PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY GOVERNMENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY LAB SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY LARGE SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PILOT SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY INSECT CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MAMMALIAN CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MICROBIAL FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PLANT CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 71. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 72. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 73. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 77. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 81. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 126. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 127. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 128. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 132. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 133. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 135. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 136. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 137. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 141. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 151. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 153. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 154. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 155. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 159. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 160. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 162. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 163. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 164. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 196. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 198. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 199. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 200. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 204. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 214. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 216. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 217. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 218. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 222. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 223. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 225. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 226. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 227. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 231. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 240. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 250. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 252. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 253. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 254. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 258. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 259. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 261. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 262. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 263. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 267. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 277. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 278. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 279. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 280. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 281. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 285. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 286. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 287. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 288. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 289. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 290. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 294. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 312. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 313. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 314. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 315. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 316. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 317. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 318. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 319. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 322. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 323. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 324. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 325. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 326. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 327. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 328. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 331. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 332. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 333. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 334. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 335. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 336. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 337. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 340. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 341. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 342. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2

Companies Mentioned

The companies profiled in this Upstream Bioprocessing market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Sartorius AG
  • Merck KGaA
  • Lonza Group AG
  • Corning Incorporated
  • Eppendorf AG
  • Bio-Rad Laboratories, Inc.
  • Repligen Corporation
  • Takara Bio Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 13.81 Billion
Forecasted Market Value ( USD ) by 2030 $ 26.07 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Upstream Bioprocessing Market Size, Share & Trends Analysis Report by Product (Bioreactors/Fermenters, Cell Culture Products), Workflow (Media Preparation, Cell Culture), Use Type (Multi-use, Single-use), Mode, Region, and Segment Forecasts, 2024-2030 - Product Image

Upstream Bioprocessing Market Size, Share & Trends Analysis Report by Product (Bioreactors/Fermenters, Cell Culture Products), Workflow (Media Preparation, Cell Culture), Use Type (Multi-use, Single-use), Mode, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Large and Small-Scale Bioprocessing Market Size, Share & Trends Analysis Report by Workflow (Downstream, Upstream), Product, Use Type, Mode (in-House, Outsourced), and Region with Growth Forecasts, 2025-2030 - Product Image

Large and Small-Scale Bioprocessing Market Size, Share & Trends Analysis Report by Workflow (Downstream, Upstream), Product, Use Type, Mode (in-House, Outsourced), and Region with Growth Forecasts, 2025-2030

  • Report
  • 110 Pages
  • Global
From
Single-use Bioprocessing Market - Global Forecast to 2030 - Product Image

Single-use Bioprocessing Market - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Single-use Bioprocessing Sensors & Probes Market - Global Forecast to 2030 - Product Image

Single-use Bioprocessing Sensors & Probes Market - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Upstream Bioprocessing - Global Strategic Business Report - Product Image

Upstream Bioprocessing - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From

About the Upstream Bioprocessing Market

The Upstream Bioprocessing market is a segment of the biotechnology industry that focuses on the production of biopharmaceuticals. This includes the development of processes and technologies for the production of biopharmaceuticals, such as cell culture, fermentation, and purification. Upstream bioprocessing is a critical step in the development of biopharmaceuticals, as it is responsible for the production of the active pharmaceutical ingredient (API). Upstream bioprocessing technologies are used to optimize the production of biopharmaceuticals, including the development of cell lines, media, and process conditions. These technologies are also used to improve the efficiency and cost-effectiveness of biopharmaceutical production. Some companies in the Upstream Bioprocessing market include Merck KGaA, Thermo Fisher Scientific, GE Healthcare, Lonza, and Sartorius AG. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.